Compare SRBK & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRBK | GNTA |
|---|---|---|
| Founded | 1887 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.7M | 34.0M |
| IPO Year | N/A | 2021 |
| Metric | SRBK | GNTA |
|---|---|---|
| Price | $16.20 | $1.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 36.6K | ★ 92.8K |
| Earning Date | 01-30-2026 | 03-30-2026 |
| Dividend Yield | ★ 1.23% | N/A |
| EPS Growth | ★ 374.69 | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $31,130,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $29.90 | ★ N/A |
| Revenue Growth | ★ 0.85 | N/A |
| 52 Week Low | $11.36 | $1.28 |
| 52 Week High | $17.11 | $10.00 |
| Indicator | SRBK | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 55.61 | 36.07 |
| Support Level | $16.12 | $1.28 |
| Resistance Level | $17.08 | $1.68 |
| Average True Range (ATR) | 0.44 | 0.17 |
| MACD | -0.07 | 0.02 |
| Stochastic Oscillator | 47.64 | 27.42 |
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.